Stock Screener ETF Screener

Penny Stock Screener Technical Analysis Screener

Dividend Center Best Dividend Stocks

Best High Yield Dividend Stocks Dividend Aristocrats Dividend Stock Comparison

Dividend Calculator Dividend Returns Comparison Dividend Calendar

My Experts Top Analysts Top Financial Bloggers Top-Performing Corporate Insiders Top Hedge Fund Managers Top Research Firms Top Individual Investors

Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire Arrived EquityMultiple

Follow Us

TOOLS

Top Insiders Stocks

Notification Center

Top Smart Score Stocks

Plans & Pricing

Research Tools

Trending Stocks

Most Visited Websites

Daily Feeds

Daily Analyst Ratings

Daily Insider Trading Tracker

Calendars

Earnings Calendar

Dividend Calendar

Economic Calendar

Market Holidays

Economic Indicators

Economic Indicators Center

Unemployment Rate

Federal Funds Rate

Class Actions

Calculators

Dividend Calculator

Dividend Yield Calculator

Options Profit Calculator

Dollar Cost Averaging

Penny Stock Screener

Technical Analysis Screener

Dividend Center

Best Dividend Stocks

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Enterprise Solutions

Education

How To Use TipRanks

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

TipRanks News Wire

Follow Us

Recursion Pharmaceuticals (RXRX)

NASDAQ:RXRX

US Market

RXRX

Recursion Pharmaceuticals

Analyst Forecasts

Technical Analysis

RESEARCH TOOLS

Top Analyst Stocks

Top Smart Score Stocks

reports

Recursion Pharmaceuticals (RXRX) Stock News & Sentiment

2,839 Followers

Recursion Pharmaceuticals’ (RXRX) AI Approach to Drug Discovery Shows Progress

Market News

Recursion Pharmaceuticals’ (RXRX) AI Approach to Drug Discovery Shows Progress

12d ago

Cautious Optimism for Recursion Pharmaceuticals Amid Promising REC-994 Data and Awaited Pipeline Updates

Ratings

Cautious Optimism for Recursion Pharmaceuticals Amid Promising REC-994 Data and Awaited Pipeline Updates

14d ago

Promising Phase II Results for Recursion Pharmaceuticals’ REC-994 Bolster Buy Rating

Ratings

Promising Phase II Results for Recursion Pharmaceuticals’ REC-994 Bolster Buy Rating

15d ago

Moderna (MRNA) Surges after Oracle’s Larry Ellison Praises AI-Driven Cancer Vaccines

Market News

Moderna (MRNA) Surges after Oracle’s Larry Ellison Praises AI-Driven Cancer Vaccines

30d ago

Recursion Pharmaceuticals Showcases Progress at JP Morgan Conference

Company Announcements

Recursion Pharmaceuticals Showcases Progress at JP Morgan Conference

1M ago

Recursion Pharmaceuticals CFO Ben Taylor to Join Exscientia

Company Announcements

Recursion Pharmaceuticals CFO Ben Taylor to Join Exscientia

3M ago

Recursion Pharmaceuticals’ (RXRX) Bold Acquisition Places it as an Industry Leader

Market News

Recursion Pharmaceuticals’ (RXRX) Bold Acquisition Places it as an Industry Leader

3M ago

More RXRX News >

RXRX News on the Web

2025-02-19

Why Recursion Pharmaceuticals, Inc. is the Best Performing Healthcare Stock So Far in 2025

Yahoo Finance

Neutral

2025-02-19

Altitude Lab Launches Pre-seed Venture Fund, Anchored by Recursion CEO Chris Gibson, Enabling SBIR-awarded Biotechs Hit by Funding Gap to Build in Salt Lake City

Yahoo Finance

Neutral

2025-02-19

Recursion CEO launches pre-seed fund in response to NIH cuts

BioPharma Dive

Neutral

2025-02-18

Why Jensen Huang’s Company Is Betting On Recursion Pharmaceuticals, Inc.

Yahoo Finance

Neutral

2025-02-18

Altitude Lab Startups Raise $154M in Capital

Yahoo Finance

Neutral

2025-02-18

Recursion Pharmaceuticals Before Q4 Earnings: How to Play the Stock

Yahoo Finance

Neutral

2025-02-17

Nvidia shocks investors, buys and sells popular AI stocks

TheStreet.com

Neutral

2025-02-17

Why Recursion Pharmaceuticals, Inc. Soared Last Week

Yahoo Finance

Neutral

News Score - Last 7 Days

Neutral

RXRX

Sector Average

Media Buzz

This Week10 articles

Weekly Average6.25 articles

News Sentiment

This Week50%

Sector Average57%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is RXRX’s Media Buzz Sentiment?

10 articles about RXRX were published this week. In an average week, 6.25 articles are published.

What is RXRX’s weekly average amount of articles?

In an average week, 6.25 articles about RXRX are published.

What is RXRX’s News Sentiment?

50% of articles about RXRX were positive this week, compared to its sector average of 57%.

Healthcare Stocks that are Trending in the News

RCUSArcus Biosciences

SHGSingular Health Group Ltd

HCMHUTCHMED

PENPenumbra

AMNAMN Healthcare Services

Showing the stocks with the most bullish news sentiment over the past week

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing